# Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin

> **NCT00385931** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 412 (actual)

## Conditions studied

- Hypertension
- Hypercholesterolemia
- Dyslipidemia

## Interventions

- **DRUG:** Valsartan and simvastatin

## Key facts

- **NCT ID:** NCT00385931
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2003-04
- **Final completion:** 2003-04
- **Target enrollment:** 412 (ACTUAL)
- **Last updated:** 2023-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00385931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00385931, "Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00385931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*